Subject(s)
COVID-19 , Pityriasis Rubra Pilaris , ChAdOx1 nCoV-19 , Humans , Isotretinoin/therapeutic useSubject(s)
COVID-19/complications , Self Report , Skin Diseases/diagnosis , Skin Diseases/epidemiology , Adult , Aged , Brazil/epidemiology , COVID-19/epidemiology , Female , Humans , Male , Middle Aged , Pandemics , Prevalence , SARS-CoV-2 , Surveys and QuestionnairesSubject(s)
Keratosis, Actinic , Photochemotherapy , Skin Neoplasms , Aminolevulinic Acid/analogs & derivatives , Colchicine , Forearm , HumansABSTRACT
Many epidemiological studies and clinical trials have been performed concerning actinic keratoses. The most eligible endpoint in the majority of articles is counting of actinic keratoses before and after treatments, nevertheless some authors support that this is not a reliable form of evaluation. The aim of this study was to evaluate the actinic keratoses counting by various raters and suggest approaches to increase the reliability. Cross-sectional study: forty-three patients were evaluated by four raters (inter- and intra-rater assessment) on the face and forearms. The mean actinic keratoses counts on the face and forearms were 7.7 and 9.1. The overall agreement among the raters for the facial and forearm actinic keratoses was 0.74 and 0.77. The intra-rater assessment showed high rates of agreement for the face (ICC=0.93) and forearms (ICC=0.83). Higher agreement occurred when counting up to five lesions. Four raters led to increased measurement variability and loss of reliability. Higher rates of agreement may be achieved with small number of lesions, limitation and/or segmentation of body areas to reduce their number, in AK prevention designs, are strategies that may lead to a greater reliability of these measurements.
Subject(s)
Keratosis, Actinic/diagnosis , Keratosis, Actinic/pathology , Aged , Aged, 80 and over , Cross-Sectional Studies , Face/pathology , Female , Forearm/pathology , Humans , Male , Middle Aged , Reproducibility of Results , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology , Ultraviolet Rays/adverse effectsABSTRACT
A acropigmentação reticulada de Dohi é desordem pigmentar classificada dentro das discromatoses, localizada nas extremidades, cuja herança geralmente é autossômica dominante ou, mais raramente, recessiva. Foi primeiramente descrita no Japão e, embora seja doença genética de ocorrência rara, pode mimetizar várias doenças como: vitiligo acral, dermatite de contato hipocromiante e Doença de Dowling-Degos. Relatamos um caso de acropigmentação de Dohi, do sexo masculino, sem história familiar, salientando a importância dos seus diagnósticos diferenciais (AU)
Reticulate acropigmentation of Dohi (RAD) is a pigmentary disorder classified as a dyschromatosis, localized in the extremities, which inheritance generally is autosomal dominant, or more rarely, recessive. It was first described in Japan and, although of sporadic occurrence, it can mimic many diseases such as: acral vitiligo, hypochromiant contact dermatitis and Dowling-Degos disease. We discuss a case of Dohi`s acropigmentation, in a male, without family history, focusing on the importance of its differential diagnosis (AU)